Table 1. Dysregulated lncRNAs involved in DR.
LncRNA | Dysregulation | Tissues and cell type | Pathogenic functions | Possible mechanism | References |
---|---|---|---|---|---|
MIAT | Up-regulated | Retinas of DM rats; RF/6A, RPE, RGC and Müller cells | Promotes EC proliferation, migration, and tube formation in vitro | NF-κB activation | [96–98] |
Aggravates retinal vessel impairments and visual dysfunction in vivo | |||||
MALAT1 | Up-regulated | Retinas of DM mice; RF/6A | Promotes EC proliferation, migration, and tube formation in vitro | Cross-talks with p38 MAPK signaling pathway | [99–101] |
Deteriorates retinal NV in vivo | Activates inflammatory pathway via TNF-α and IL-6 | ||||
MEG3 | Down-regulated | Retinas of DM mice; RF/6A | Regulates ECl proliferation, migration, and tube formation in vitro | Activates PI3K-Akt signaling pathway | [102] |
Aggravates retinal vessel dysfunction in vivo | |||||
SOX2OT | Down-regulated | Retinas of DM mice; RGCs | Decreases cell viability and increases cell apoptosis in vitro | Antioxidative via regulation of NRF2/HO-1 signaling activity | [103] |
Promotes neurodegeneration in vivo | |||||
RNCR3 | Up-regulated | Retinas of DM mice; RF/6A, Müller cells | Increases cell viability and proliferation, promotes EC migration and tube formation in vitro | Related to the release of several cytokines | [104,105] |
Aggravates retinal cell apoptosis, visual function, and microvascular leakage in vivo | |||||
ANRIL | Up-regulated | Retinas of DM mice; HRECs | Increases retinal microvascular permeability in vivo | Increases VEGF mediated by PRC2 complex and p300 | [106] |
BDNF-AS | Up-regulated | ARPE-19 | Increases cell apoptosis in vitro | Not only via BDNF-associated pathways | [107,108] |
Abbreviations: ANRIL, antisense RNA to INK4 locus; BDNF-AS, brain-derived neurotrophic factor antisense; MALAT1, metastasis-associated lung adenocarcinoma transcript 1; MEG3, maternally expressed gene 3; MIAT, myocardial infarction associated transcript; NRF2/HO-1, nuclear factor erythroid 2 related factor 2/heme oxygenase-1; PRC2, polycomb repressor complex 2; RNCR2, retinal ncRNA 2; SOX2OT, SOX2 overlapping transcript.